12:00 AM
 | 
Mar 05, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Ulimorelin: Completed Phase III enrollment

Tranzyme and Norgine completed enrollment of about 330 patients who have undergone partial bowel resection in the double-blind, placebo-controlled, international Phase III ULISES 008 trial evaluating daily 160...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >